Canada markets open in 40 minutes

Telix Pharmaceuticals Limited (TLPPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.45-0.24 (-2.76%)
At close: 01:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.69
Open8.84
BidN/A x N/A
AskN/A x N/A
Day's Range8.44 - 8.88
52 Week Range4.59 - 9.11
Volume2,409
Avg. Volume5,156
Market Cap2.738B
Beta (5Y Monthly)2.35
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain

    Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first bladder cancer sentinel lymph node (SLN) procedure with SENSEI®, Telix's miniature robotic-assisted gamma probe used to detect radiation in patients and guide surgery. The patient was operated on at Hospital del Mar in Barcelona, Spain.

  • PR Newswire

    QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy

    Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH (ABX-CRO), a full-service contract research organisation (CRO) based in Dresden, and its development partner, Stockholm-based Quantinm AB.

  • GlobeNewswire

    QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy

    MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH (ABX-CRO), a full-service contract research organization (CRO) based in Dresden, and its development partner, Stockholm-based Quantinm AB. QDOSE® is a validated, versatile